Transporter of thyroid hormones crucial for embryonal brain development
thyroid hormones are very important for the development of the brain. And when the transporters of these hormones are not functioning properly, the consequences for the development of the cerebellum or 'the little brain' are very serious. These are the findings of a study by researchers from KU Leuven (University of Leuven, Belgium) and King's College London.

A cross-section of the folded cerebellar cortex or 'little brain' of a chicken embryo, with three layers of cells. The middle layer consists of Purkinje cells with their characteristic dendritic branches. This image shows healthy Purkinje cells, highlighted in bright colours. With a deactivated MCT8 transporter, the Purkinje cells would have much smaller dendritic branches.
KU Leuven Lab of Comparative Endocrinology - Joke Delbaere & Pieter Vancamp
Thyroid hormones control our everyday metabolism, but they're already crucial before birth: they are essential for the development of the organs, including the brain. "These hormones ensure that different cell types originate in the brain at the right moment, move to the right place, and make the right connections," explains Professor Veerle Darras from the Lab of Comparative Endocrinology at KU Leuven. "Until the thyroid is fully developed, a foetus depends on the mother's hormones. If the mother-to-be doesn't produce enough thyroid hormones, this has a negative impact on the brain development of the foetus from a very early stage."
Determining whether the thyroid is properly functioning is typically done by measuring the amount of hormones in the blood. Unfortunately, this is not always a good indicator. "This proved to be the case with the rare Allan-Herndon-Dudley syndrome (AHDS), a hereditary condition of the nervous system that only affects boys. These children suffer from severe mental retardation and locomotor deficits. Doctors looked for possible thyroid hormone deficiencies but, surprisingly, the level of hormones in the blood was abnormally high. The problem turned out to be in the transporters that bring the hormones from the blood to the inside of the cell. Due to a genetic mutation an important transporter - MCT8 - is deactivated in patients with AHDS."
To find out more about this mutation Professor Darras's team examined what happens in a chicken embryo when this transporter is deactivated in a part of the little brain, PhD student Pieter Vancamp continues. "The little brain is important for locomotion. A thyroid hormone deficiency impairs its development, but the role of the transporters was not yet known. In our study, we noticed relatively quickly that some important proteins - necessary for the development of brain cells - were not produced in sufficient amounts in the part of the brain with no active transporter. In a later stage, we noticed that the Purkinje cells - nerve cells located in the cortex of the little brain - have less dendritic branches. Therefore, brain cell signalling goes haywire, and problems arise in other cells as well."
The results show that thyroid hormones are essential for embryonic development right from the start. "The earlier things go wrong, the harder it is to repair the damage after birth. Newborns are always screened for thyroid problems with the heel prick, but it's better to test the mothers-to-be as early as possible. Unfortunately, this does not yet happen in all hospitals. For the Allan-Herndon-Dudley syndrome, in particular, our study raises questions about possible prenatal treatments with variants of thyroid hormones: these can enter the cell without the transporter. But this is still an experimental treatment - one that is only being tested after birth."
Original publication
Original publication
Joke Delbaere, Pieter Vancamp, Stijn L J Van Herck, Nele M A Bourgeois, Mary J Green, Richard J T Wingate and Veerle M Darras; "MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development"; Jounral of Endoncrinology; 2016
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Natural killer cells – the body’s own patrol against viruses and tumours - Setting the stage for personalised medicine, researchers decode major immune cell's protein content
Experimental drug shows promise against brain, prostate cancers
New screening technique paves the way for protein drugs from bacteria
Tobacco plants yield the first vaccine for the dreaded 'cruise ship virus'
Lithium safe, effective for children with bipolar disorder
